BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34022215)

  • 1. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
    Ann Thorac Surg; 2022 Apr; 113(4):1317-1324. PubMed ID: 34022215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Imai K; Ito H; Nakayama H; Ikeda N; Yoshimura K; Okada M
    Ann Thorac Surg; 2021 Mar; 111(3):1044-1051. PubMed ID: 32795524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
    Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
    Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmentectomy Is Equivalent to Lobectomy in Hypermetabolic Clinical Stage IA Lung Adenocarcinomas.
    Kamel MK; Rahouma M; Lee B; Harrison SW; Stiles BM; Altorki NK; Port JL
    Ann Thorac Surg; 2019 Jan; 107(1):217-223. PubMed ID: 30240764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Ito H; Nakayama H; Ikeda N; Okada M
    Eur J Cardiothorac Surg; 2020 Dec; 58(6):1245-1253. PubMed ID: 32893296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Okada M
    Eur J Cardiothorac Surg; 2020 Jan; 57(1):114-121. PubMed ID: 31230086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.
    Tsutani Y; Handa Y; Shimada Y; Ito H; Ikeda N; Nakayama H; Yoshimura K; Okada M
    J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1244-1252.e1. PubMed ID: 33213872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study.
    Li F; Zhao Y; Yuan L; Wang S; Mao Y
    J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes.
    Roman M; Labbouz S; Valtzoglou V; Ciesla A; Hawari M; Addae-Boateng E; Thorpe JA; Duffy JP; Majewski A
    Eur J Surg Oncol; 2019 May; 45(5):845-850. PubMed ID: 30409440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Sekino Y; Tsutani Y; Nakajima R; Aokage K; Saji H; Tsuboi M; Okada M; Asamura H; Nakamura K; Fukuda H; Watanabe SI; ;
    Lancet Respir Med; 2024 Feb; 12(2):105-116. PubMed ID: 38184010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    Clin Lung Cancer; 2022 Jul; 23(5):393-401. PubMed ID: 35589544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmentectomy vs Lobectomy for Early Non-Small Cell Lung Cancer With Visceral Pleural Invasion.
    Mathey-Andrews C; Abruzzo AR; Venkateswaran S; Potter AL; Senthil P; Beqari J; Yang CJ; Lanuti M
    Ann Thorac Surg; 2024 May; 117(5):1007-1014. PubMed ID: 37419171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing Segmentectomy and Lobectomy for Clinical Stage IA Solid-dominant Lung Cancer Measuring 2.1 to 3 cm.
    Kamigaichi A; Tsutani Y; Kagimoto A; Fujiwara M; Mimae T; Miyata Y; Okada M
    Clin Lung Cancer; 2020 Nov; 21(6):e528-e538. PubMed ID: 32482526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.
    Landreneau RJ; Normolle DP; Christie NA; Awais O; Wizorek JJ; Abbas G; Pennathur A; Shende M; Weksler B; Luketich JD; Schuchert MJ
    J Clin Oncol; 2014 Aug; 32(23):2449-55. PubMed ID: 24982447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy for small-sized stage IA lung cancer.
    Zhong C; Fang W; Mao T; Yao F; Chen W; Hu D
    Ann Thorac Surg; 2012 Aug; 94(2):362-7. PubMed ID: 22727321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer.
    Tsubokawa N; Tsutani Y; Miyata Y; Handa Y; Misumi K; Hanaki H; Hida E; Okada M
    World J Surg; 2018 Aug; 42(8):2493-2501. PubMed ID: 29423740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Flossdorf S; Passlick B; Hecker E; Kugler C; Eichhorn M; Krbek T; Eggeling S; Hatz R; Müller MR; Hillinger S; Aigner C; Jöckel KH
    Lung Cancer; 2022 Oct; 172():108-116. PubMed ID: 36058174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.